Bursa Community
Would you like to react to this message? Create an account in a few clicks or log in to continue.

Hot Stock KPJ rises 4.3% after RHB upgrade to 'buy' with higher target price

Go down

Hot Stock KPJ rises 4.3% after RHB upgrade to 'buy' with higher target price Empty Hot Stock KPJ rises 4.3% after RHB upgrade to 'buy' with higher target price

Post by Cals Thu 02 Jul 2015, 01:09

Hot Stock
KPJ rises 4.3% after RHB upgrade to 'buy' with higher target price




[You must be registered and logged in to see this image.]

By Yimie Yong / theedgemarkets.com   | July 1, 2015 : 5:16 PM MYT  

KUALA LUMPUR (July 1): Shares of [size=14]KPJ Healthcare Bhd ([You must be registered and logged in to see this image.] Financial Dashboard) rose as much as 4.3% or 18 sen to RM4.40 today, after RHB Research upgraded its rating from “neutral” to “buy” with a higher target price of RM5.10.


At 4.15pm, KPJ (fundamental: 0.95; valuation: 1.1 ) pared down some gains to trade at RM4.36, up 14 sen or 3.32% with 2.51 million shares changing hands. The trading volume saw a surge compared to yesterday’s trading volume which saw some 491,200 shares done.

RHB Research said it likes KPJ for its strong earnings growth outlook amid robust demand for private healthcare services and it expects 17% earnings compound annual growth rate (CAGR) over financial year ended Dec 31, 2014 (FY14) to FY17.

After revamping its earnings model, the research house mostly kept its FY15 forecasts, but raised FY16 and FY17 earnings estimates by 7.8% and 13.9% respectively to incorporate the new capacity at its existing hospital and to reflect its updated pipeline.

“On revised earnings, the stock currently trades at 28 times and 14 times its 12-month forward price-earnings (P/E) and enterprise value to earnings before interest, tax, depreciation, and amortization (EV/EBITDA) respectively. Both multiples are at a discount to its 3-year historical mean.”

“We see no real reason for the discount as KPJ’s fundamentals have strengthened after its earnings disappointments in FY12 and FY13,” it added.

Therefore, RHB Research upgraded the rating to buy, with a new sum-of-parts derived target price of RM5.10, from RM4.25.

(Note: The Edge Research's fundamental score reflects a company’s profitability and balance sheet strength, calculated based on historical numbers. The valuation score determines if a stock is attractively valued or not, also based on historical numbers. A score of 3 suggests strong fundamentals and attractive valuations.)
[/size]
Cals
Cals
Administrator
Administrator

Posts : 25277 Credits : 57721 Reputation : 1766
Male Join date : 2011-09-08
Location : global
Comments : “My plan of trading was sound enough and won oftener that it lost. If I had stuck to it I’️d have been right perhaps as often as seven out of ten times.”
Stock Exposure : Technical Analysis / Fundamental Analysis / Mental Analysis

Back to top Go down

Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum